» Articles » PMID: 39766785

Disentangling the Genetic Landscape of Peripartum Depression: A Multi-Polygenic Machine Learning Approach on an Italian Sample

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2025 Jan 8
PMID 39766785
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The genetic determinants of peripartum depression (PPD) are not fully understood. Using a multi-polygenic score approach, we characterized the relationship between genome-wide information and the history of PPD in patients with mood disorders, with the hypothesis that multiple polygenic risk scores (PRSs) could potentially influence the development of PPD.

Methods: We calculated 341 PRSs for 178 parous mood disorder inpatients affected by major depressive disorder (MDD) or bipolar disorder (BD) with ( = 62) and without ( = 116) a history of PPD. We used partial least squares regression in a novel machine learning pipeline to rank PRSs based on their contribution to the prediction of PPD, in the whole sample and separately in the two diagnostic groups.

Results: The PLS linear regression in the whole sample defined a model explaining 27.12% of the variance in the presence of PPD history, 56.73% of variance among MDD, and 42.96% of variance in BD. Our findings highlight that multiple genetic factors related to circadian rhythms, inflammation, and psychiatric diagnoses are top contributors to the prediction of PPD. Specifically, in MDD, the top contributing PRS was monocyte count, while in BD, it was chronotype, with PRSs for inflammation and psychiatric diagnoses significantly contributing to both groups.

Conclusions: These results confirm previous literature about the immune system dysregulation in postpartum mood disorders, and shed light on which genetic factors are involved in the pathophysiology of PPD.

References
1.
Kerlan V, Nahoul K, Le Martelot M, Bercovici J . Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol (Oxf). 1994; 40(2):263-7. DOI: 10.1111/j.1365-2265.1994.tb02478.x. View

2.
Poletti S, Zanardi R, Mandelli A, Aggio V, Finardi A, Lorenzi C . Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers. Brain Behav Immun. 2024; 118:52-68. DOI: 10.1016/j.bbi.2024.02.019. View

3.
Bauer A, Liu X, Byrne E, Sullivan P, Wray N, Agerbo E . Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders. Transl Psychiatry. 2019; 9(1):288. PMC: 6848186. DOI: 10.1038/s41398-019-0629-9. View

4.
Di Florio A, Forty L, Gordon-Smith K, Heron J, Jones L, Craddock N . Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry. 2012; 70(2):168-75. DOI: 10.1001/jamapsychiatry.2013.279. View

5.
Viktorin A, Meltzer-Brody S, Kuja-Halkola R, Sullivan P, Landen M, Lichtenstein P . Heritability of Perinatal Depression and Genetic Overlap With Nonperinatal Depression. Am J Psychiatry. 2015; 173(2):158-65. DOI: 10.1176/appi.ajp.2015.15010085. View